Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,197.00    -18.00 (-1.48%)
Bid:
1,198.00
Ask:
1,200.00
Spread: 2.00 (0.167%)
Market Cap: £832.43m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisition

7 Oct 2008 07:00

RNS Number : 2159F
CVS Group plc
07 October 2008
 



For Immediate Release

7 October 2008

CVS Group plc

("CVS" or the "Company")

Acquisition of Rossendale Pet Crematorium Limited

CVS, one of the UK's leading providers of veterinary services, is pleased to announce the acquisition of Rossendale Pet Crematorium Limited ('the crematorium').

 

The acquisition, which includes the freehold property from which the crematorium operates, has been financed wholly from the Company's cash flow, continuing to demonstrate the ability of the Company to finance its acquisition pipeline directly from internally generated cash.

 

Based in Lancashire, within a thirteen acre site, the crematorium and Memorial Gardens were established in 1967, aiming to provide bereaved pet owners with the best and widest options in coping with the death of their pets. 

CVS will assume all management responsibilities for the crematorium following completion of the acquisition including the nine current employees.

In the year ended 31 December 2007the crematorium achieved an Operating Profit of £136,000 on turnover of £490,000 and had gross assets of £503,000.

The acquisition of a crematorium will be a great enhancement to CVS' existing portfolio of 151 veterinary surgeries and veterinary laboratoriesFurther broadening the veterinary services offering, the acquisition provides a new division which, in line with CVS' stated strategy, will allow the Company to continue to generate stronger returns through vertical integration of key suppliers to the veterinary market.

CVS owned practices send minimal levels of work to the crematorium, therefore providing the opportunity for CVS surgeries to cascade work there post completion, where logistically suitable.

Commenting on the acquisition, CVS Chief Executive Simon Innes said: 

"The acquisition of Rossendale Pet Crematorium is an important addition to the CVS group of businesses as well as a natural progression for our Company. In line with all acquisitions to date, it offers a high quality business with dedicated professionals.

The potential for cost synergies means that we will enhance our shareholder returns at the same time as improving our client offering."

Contacts:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

Buchanan Communications

Richard Oldworth

Suzanne Brocks

020 7466 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQILFITIVLRIIT
Date   Source Headline
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights
29th Sep 202210:34 amRNSHolding(s) in Company
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20224:19 pmRNSDirector/PDMR Shareholding
26th Sep 202211:56 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
23rd Sep 20227:00 amRNSDirector/PDMR Shareholding
22nd Sep 20227:00 amRNSFinal Results for the year ended 30 June 2022
31st Aug 20227:00 amRNSExercise of Options and Total Voting Rights
9th Aug 20229:30 amRNSHolding(s) in Company
29th Jul 20227:00 amRNSExercise of Options and Total Voting Rights
28th Jul 20227:00 amRNSTrading Update
13th Jul 20227:00 amRNSAppointment of Nominated Advisor and Joint Brokers
12th Jul 20227:00 amRNSBlock Listing Interim Review and TVR Update
1st Jul 20227:00 amRNSConclusion of CMA process, acquisition and trading
30th Jun 20227:00 amRNSExercise of Options and Total Voting Rights
13th Jun 20223:00 pmRNSPostponement to Capital Markets Day
8th Jun 20221:54 pmRNSHolding(s) in Company
31st May 20227:00 amRNSExercise of Options and Total Voting Rights
6th May 20227:00 amRNSAcquisition of Anton Vets
29th Apr 20227:00 amRNSExercise of Options and Total Voting Rights
31st Mar 20227:00 amRNSExercise of Options and Total Voting Rights
28th Mar 202210:47 amRNSHolding(s) in Company
24th Mar 20222:54 pmRNSDirector/PDMR Shareholding
24th Mar 202210:03 amRNSHolding(s) in Company
24th Mar 20227:00 amRNSInterim Results
21st Mar 20229:14 amRNSHolding(s) in Company
18th Mar 202210:17 amRNSHolding(s) in Company
3rd Mar 20228:38 amRNSHolding(s) in Company
28th Feb 20227:00 amRNSExercise of Options and Total Voting Rights
21st Feb 20225:37 pmRNSHolding(s) in Company
18th Feb 20227:15 amRNSCMA Update
3rd Feb 20229:43 amRNSHolding(s) in Company
31st Jan 20227:00 amRNSExercise of Options and Total Voting Rights
27th Jan 20227:00 amRNSTrading Update
13th Jan 20221:43 pmRNSBlock Listing Interim Review and TVR Update
4th Jan 20227:00 amRNSExercise of Options, PDMR Dealing and TVR
31st Dec 20217:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20212:37 pmRNSBlock Listing Application
17th Dec 20211:41 pmRNSGrant of Options
15th Dec 202111:30 amRNSPDMR/PCA Dealings
13th Dec 20217:00 amRNSPDMR/PCA Dealings
7th Dec 202111:06 amRNSPDMR/PCA Dealings
30th Nov 20217:00 amRNSExercise of Options and Total Voting Rights
26th Nov 20215:31 pmRNSHolding(s) in Company
26th Nov 20215:24 pmRNSHolding(s) in Company
26th Nov 20218:16 amRNSGrant of Options & PDMR Dealing
26th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20213:09 pmRNSResult of AGM
24th Nov 20217:00 amRNSAGM Statement and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.